EHS Task Force

2022 Programme


27 January 2022

Closed meeting working group

AI in Healthcare

24 February 2022



Yiannos Tolias
Legal Officer DG SANTÉ, European Commission

Elke Grooten 
Head EU Relations, Novartis

Michele Calabrò
Senior Manager for Digital Health Policy, Digital Europe

Sara Roda
EU Senior Policy Adviser, Standing Committee of European Doctors

Cornelia Kutterer
Senior Director, Rule of Law & Responsible Tech, European Government Affairs, Microsoft

Birgit Bauer
Digital Health & Social Media Entrepreneur and Consultant, Patient Expert, Manufaktur für Antworten UG

Dipak Kalra
President of The European Institute for Innovation through Health Data

21 April 2022

Closed meeting group

HERA and pandemic preparedness 

19 May 2022

Closed meeting group


16 June 2022

EHS Task force Public debate: HERA and pandemic preparedness

Frank Vandenbroucke
Minister of Social Affairs and Public Health, Belgium

Pierre Delsaux
Director General, HERA, European Commission

Ben Osborn 
Regional President, International Developed Markets, Pfizer Hospital

Prof. Dr. Dirk Ramaekers 
Head of the Task Force Covid 19 Vaccination Strategy, Belgian Government

Elke Grooten
Head of EU Relations, Novartis

Elena Azzolini
Head of Vaccinal Hub Covid-19 Humanitas

Teri Schultz 
EU Correspondent

The European Commission’s Health Emergency preparedness and Response Authority (HERA) was set up in 2021 to enhance Europe`s ability to quickly respond to cross border healthcare threats and ensure health security. It will do so by ensuring the timely development, manufacture, procurement, and equitable distribution of essential medical countermeasures, by relying on a strong public private partnership. HERA is currently operational. However, certain gaps and unclarities still remain and this panel will gather relevant cross-sectorial actors to discuss and address them.

6 October 2022 

Closed meeting group

The economics of competitive and resilience european Healthcare

10 November 2022


EHS Task Force PUBLIC debate: Understanding the value of gene therapy.The journey from the lab to patients

Jo de Cock
Chairman of the Belgian National Committee for Physicians and Health Insurance Funds

Hildegard Büning
President European Society of Gene and Cell Therapy

Sol Ruiz 
Member of the CAT committee, European Medicines Agency, Spanish Medicines Agency

Walter Van Dyck
Co Executive Director at the Health Science and Business Institute, KU Leuven and Vlerick Business School

Dirk Vander Mijnsbrugge.                            Medical Affairs Lead, Rare Diseases, Pfizer

Simone Boselli
Public Affairs Director, Eurordis

Damian Gilkerson                                      Executive Director, Therapeutic Area Head, Commercial Operations, Europe CSL Behring

8 December 2022

EHS Task Force PUBLIC debate: Ensuring Europe`s competitiveness in health and fostering an economic resilience in a post pandemic world

Taking place in the context of the annual European Health Summit